| 股票 | 标签 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▴ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 博迅生物 920504 | 中性 | 医疗器械 | 45.4 | — | — | 4.03 | 1.1% | 59% | 40% | 19% | 0.8 | 1.1% | -6% | +37% | -21% | — | — | — | 8 |
| 辰光医疗 920300 | 亏损或困境 | 医疗器械 | — | — | — | 5.63 | — | — | 40% | 31% | — | -0.4% | -22% | +32% | -34% | — | — | — | 9 |
| 鹿得医疗 920278 | 中性 | 医疗器械 | 88.0 | — | — | 2.97 | 1.5% | 63% | 25% | 30% | 1.9 | -2.6% | -4% | +27% | -26% | — | — | — | 11 |
| 中科美菱 920992 | 纯久期 | 医疗器械 | 64.6 | 52.0 | 4.00 | 1.84 | 0.8% | 46% | 36% | 12% | 0.2 | 2.4% | -9% | +28% | -31% | — | — | — | 12 |
| 锦好医疗 920925 | 中性 | 医疗器械 | 715.2 | — | — | 3.29 | 0.4% | 50% | 46% | 25% | 0.7 | 0.2% | +16% | +174% | -62% | — | — | — | 12 |
| *ST益通 300430 | 亏损或困境 | 医疗器械 | — | — | — | 0.96 | — | 14% | 42% | 25% | — | -15.8% | -22% | +26% | -76% | -80% | -86% | 67% | 13 |
| 睿昂基因 688217 | 亏损或困境 | 医疗器械 | — | — | — | 1.64 | 0.7% | 129% | 73% | 38% | 0.8 | 2.8% | -25% | +44% | -7% | -21% | -45% | 43% | 14 |
| 爱得科技 920180 | 中性 | 医疗器械 | 21.6 | 16.8 | 1.29 | 1.83 | 2.5% | 34% | 59% | 18% | — | 0.1% | +2% | — | — | — | — | — | 14 |
| 海圣医疗 920166 | 中性 | 医疗器械 | 19.1 | — | — | 2.41 | — | — | 52% | 44% | 0.0 | 0.6% | +9% | — | — | — | — | — | 15 |
| 爱威科技 688067 | 中性 | 医疗器械 | 49.1 | — | — | 3.04 | 0.6% | 31% | 59% | 21% | 1.0 | 1.9% | +4% | +48% | -4% | -14% | -38% | 36% | 16 |
| 普昂医疗 920069 | 中性 | 医疗器械 | 17.9 | 15.8 | 0.53 | 2.22 | 1.5% | 24% | 48% | 0% | — | 2.6% | +16% | — | — | — | — | — | 18 |
| 科莱瑞迪 920072 | 中性 | 医疗器械 | 27.4 | — | — | 2.54 | — | — | 63% | 31% | 0.0 | 2.5% | +11% | — | — | — | — | — | 19 |
| 安必平 688393 | 亏损或困境 | 医疗器械 | — | — | — | 1.67 | 0.5% | 39% | 68% | 18% | 0.4 | -0.1% | -12% | +38% | -14% | -38% | -53% | 46% | 19 |
| 仁度生物 688193 | 纯久期 | 医疗器械 | 108.8 | — | — | 2.17 | 2.3% | 269% | 78% | 7% | 0.1 | 0.7% | -19% | +37% | +1% | -12% | -33% | 41% | 19 |
| 港通医疗 301515 | 亏损或困境 | 医疗器械 | — | — | — | 1.59 | — | 96% | 27% | 7% | — | -2.2% | -2% | +12% | -4% | -18% | -40% | 44% | 19 |
| ST迪瑞 300396 | 亏损或困境 | 医疗器械 | — | — | — | 1.26 | — | 96% | 52% | 7% | — | -4.6% | -13% | -20% | -44% | -53% | -60% | 36% | 20 |
| 爱伦医疗 920050 | 现金流红利 | 医疗器械 | 18.4 | 17.2 | 0.75 | 1.88 | 3.4% | 54% | 23% | 51% | 2.0 | -5.2% | +20% | — | — | — | — | — | 20 |
| 天臣医疗 688013 | 现金流红利 | 医疗器械 | 39.4 | — | — | 4.03 | 5.2% | 253% | 58% | 32% | 2.2 | -1.6% | +12% | +209% | -48% | -44% | -66% | 46% | 20 |
| *ST海利 603718 | 亏损或困境 | 医疗器械 | — | — | — | 2.30 | — | 29% | 59% | 8% | 1.7 | 1.6% | -14% | -11% | -48% | -57% | -64% | 40% | 21 |
| 阳普医疗 300030 | 亏损或困境 | 医疗器械 | 70.1 | — | — | 3.24 | — | — | 41% | 37% | 1.0 | 5.8% | -12% | +33% | -7% | -23% | -33% | 37% | 21 |
| 奥精医疗 688613 | 纯久期 | 医疗器械 | 251.0 | — | — | 1.51 | 0.2% | 30% | 83% | 11% | 1.0 | -1.5% | -3% | +13% | -22% | -24% | -54% | 51% | 22 |
| 康为世纪 688426 | 亏损或困境 | 医疗器械 | — | — | — | 1.79 | — | — | 65% | 22% | — | -2.9% | -28% | -17% | -12% | -14% | -55% | 47% | 24 |
| 科美诊断 688468 | 中性 | 医疗器械 | 72.2 | — | — | 1.78 | — | 36% | 75% | 24% | 2.6 | 2.9% | -11% | +9% | -14% | -28% | -37% | 27% | 25 |
| 康拓医疗 688314 | 中性 | 医疗器械 | 30.1 | 21.5 | 1.02 | 3.44 | 1.6% | 34% | 81% | 25% | 0.8 | 2.4% | +14% | +16% | -4% | -20% | -48% | 52% | 26 |
| 易瑞生物 300942 | 亏损或困境 | 医疗器械 | — | 54.4 | 1.30 | 3.26 | 0.4% | 63% | 64% | 38% | 9.3 | -0.0% | -27% | +10% | -30% | -50% | -59% | 40% | 26 |
| 西山科技 688576 | 亏损或困境 | 医疗器械 | — | 20.5 | 0.71 | 1.58 | 0.8% | 51% | 70% | 23% | — | -2.8% | +9% | +3% | -6% | -17% | -38% | 38% | 27 |
| 正海生物 300653 | 中性 | 医疗器械 | 38.7 | — | — | 3.08 | 1.8% | 61% | 89% | 21% | — | 2.4% | -6% | -4% | -24% | -32% | -39% | 34% | 27 |
| 爱朋医疗 300753 | 亏损或困境 | 医疗器械 | — | 156.0 | 11.14 | 4.19 | — | 87% | 66% | 20% | 6.9 | 1.1% | +2% | +58% | -21% | -40% | -58% | 69% | 28 |
| 南卫股份 603880 | 重资产陷阱 | 医疗器械 | — | — | — | 17.53 | — | — | 9% | 50% | — | 1.1% | +3% | +43% | +55% | +44% | -34% | 49% | 28 |
| 尚荣医疗 002551 | 亏损或困境 | 医疗器械 | — | — | — | 1.14 | — | 30% | 17% | 13% | — | -0.0% | -6% | +19% | -9% | -28% | -41% | 32% | 28 |
| 透景生命 300642 | 纯久期 | 医疗器械 | 228.4 | 216.5 | 1.34 | 1.96 | 0.9% | 70% | 66% | 19% | 4.7 | 4.8% | -20% | +32% | -5% | -39% | -64% | 59% | 28 |
| 东星医疗 301290 | 亏损或困境 | 医疗器械 | — | 23.7 | 0.35 | 1.31 | 1.1% | 62% | 49% | 14% | 1.2 | 1.6% | -4% | +12% | +12% | +4% | -36% | 39% | 28 |
| 天益医疗 301097 | 亏损或困境 | 医疗器械 | — | — | — | 2.77 | 1.0% | 46% | 38% | 42% | 6.3 | -12.3% | +13% | +44% | -5% | +6% | -36% | 51% | 28 |
| 丹娜生物 920009 | 中性 | 医疗器械 | 30.6 | 23.4 | 1.30 | 4.12 | 1.0% | 25% | 84% | 9% | 0.0 | 2.1% | -6% | — | -31% | — | — | — | 29 |
| 麦澜德 688273 | 中性 | 医疗器械 | 38.0 | 25.3 | 1.69 | 2.15 | 2.7% | 78% | 71% | 28% | 0.4 | -0.1% | +5% | +90% | -32% | -36% | -54% | 62% | 29 |
| 洁特生物 688026 | 中性 | 医疗器械 | 127.6 | 35.6 | 2.09 | 2.67 | 0.3% | 21% | 41% | 34% | 2.6 | 2.4% | -3% | +26% | +29% | +6% | -42% | 53% | 29 |
| 科华生物 002022 | 亏损或困境 | 医疗器械 | — | — | — | 1.19 | — | — | 42% | 17% | — | -3.9% | -38% | -6% | -4% | -22% | -38% | 31% | 29 |
| 汉邦科技 688755 | 中性 | 医疗器械 | 39.7 | — | — | 2.35 | 0.6% | 29% | 39% | 15% | 0.0 | 2.7% | +15% | — | -13% | -35% | -47% | 33% | 30 |
| 冠昊生物 300238 | 中性 | 医疗器械 | 178.1 | — | — | 5.25 | — | — | 77% | 42% | 3.0 | -0.2% | +1% | +15% | -17% | -34% | -42% | 44% | 31 |
| 祥生医疗 688358 | 现金流红利 | 医疗器械 | 27.3 | 22.2 | 1.11 | 2.31 | 3.1% | 79% | 59% | 9% | 0.0 | 2.4% | +5% | +30% | -3% | -15% | -37% | 50% | 32 |
| 利德曼 300289 | 亏损或困境 | 医疗器械 | — | — | — | 1.96 | — | 33% | 52% | 21% | 0.2 | 0.5% | -23% | +42% | -16% | -35% | -43% | 43% | 32 |
| 之江生物 688317 | 亏损或困境 | 医疗器械 | — | — | — | 0.99 | — | — | 62% | 16% | — | 0.9% | -62% | +24% | -16% | -42% | -45% | 45% | 32 |
| 赛科希德 688338 | 中性 | 医疗器械 | 38.6 | 35.1 | 2.34 | 1.90 | 0.8% | 31% | 62% | 17% | — | 1.5% | +5% | +9% | +19% | +10% | -33% | 46% | 32 |
| 维力医疗 603309 | 现金流红利 | 医疗器械 | 57.5 | 12.4 | 0.65 | 1.85 | 4.4% | 76% | 44% | 26% | 1.6 | 7.5% | +6% | +19% | -14% | -21% | -29% | 34% | 33 |
| 康德莱 603987 | 中性 | 医疗器械 | 14.5 | — | — | 1.17 | 2.2% | 31% | 33% | 29% | 1.5 | 10.3% | -10% | +23% | -10% | -12% | -28% | 27% | 33 |
| 戴维医疗 300314 | 中性 | 医疗器械 | 55.2 | — | — | 2.70 | 0.7% | 35% | 58% | 25% | 0.0 | 1.6% | +5% | +13% | -8% | -25% | -40% | 42% | 33 |
| 硕世生物 688399 | 亏损或困境 | 医疗器械 | — | — | — | 1.14 | 8.5% | — | 63% | 18% | 18.8 | -1.6% | -61% | +67% | -42% | -35% | -58% | 58% | 33 |
| 康众医疗 688607 | 亏损或困境 | 医疗器械 | — | 178.6 | 2.03 | 4.07 | — | 31% | 40% | 15% | — | -2.5% | +16% | +224% | -10% | +32% | -54% | 69% | 34 |
| 奥泰生物 688606 | 现金流红利 | 医疗器械 | 24.9 | — | — | 0.92 | 4.5% | 78% | 55% | 25% | 0.1 | 1.7% | -36% | +5% | -27% | -38% | -44% | 28% | 35 |
| 健尔康 603205 | 中性 | 医疗器械 | 30.8 | — | — | 2.32 | 1.1% | 31% | 24% | 23% | 0.1 | 2.0% | -2% | -2% | -21% | -26% | -37% | 26% | 35 |
| 美康生物 300439 | 中性 | 医疗器械 | 52.1 | — | — | 1.18 | 0.4% | 20% | 40% | 30% | 0.4 | 2.3% | -15% | -4% | -6% | -19% | -31% | 27% | 36 |
| *ST明德 002932 | 亏损或困境 | 医疗器械 | — | — | — | 0.67 | — | 204% | 54% | 11% | — | -2.4% | -71% | +12% | -19% | -28% | -36% | 28% | 36 |
| 迈普医学 301033 | 中性 | 医疗器械 | 29.7 | 24.7 | 0.71 | 4.48 | 1.3% | 50% | 82% | 33% | 0.1 | 2.7% | +24% | +64% | -19% | -35% | -45% | 53% | 36 |
| 拱东医疗 605369 | 中性 | 医疗器械 | 66.6 | 28.7 | 1.91 | 2.19 | 0.9% | 92% | 33% | 30% | 1.1 | 4.4% | -8% | -6% | -9% | -17% | -32% | 34% | 37 |
| 安旭生物 688075 | 纯久期 | 医疗器械 | — | — | — | 0.74 | 2.7% | 80% | 42% | 14% | 2.9 | -3.4% | -58% | +7% | -23% | -30% | -38% | 26% | 37 |
| 凯普生物 300639 | 亏损或困境 | 医疗器械 | — | — | — | 1.00 | — | 26% | 61% | 30% | 0.7 | 5.4% | -51% | -9% | +10% | -12% | -45% | 50% | 38 |
| 东方生物 688298 | 亏损或困境 | 医疗器械 | — | — | — | 0.66 | — | — | 43% | 38% | — | -10.5% | -52% | -20% | -19% | -36% | -41% | 34% | 38 |
| 乐心医疗 300562 | 中性 | 医疗器械 | 39.1 | — | — | 3.47 | 0.7% | 95% | 31% | 14% | 0.4 | 3.9% | -2% | -9% | +35% | +10% | -30% | 42% | 39 |
| 宝莱特 300246 | 亏损或困境 | 医疗器械 | — | — | — | 3.78 | 0.3% | — | 30% | 38% | 16.2 | 2.2% | -3% | +24% | +85% | +59% | -36% | 71% | 40 |
| 国科恒泰 301370 | 纯久期 | 医疗器械 | 152.8 | — | — | 1.66 | 1.4% | 33% | 12% | 9% | 7.8 | 10.7% | +3% | +9% | -25% | -23% | -35% | 28% | 41 |
| 安杰思 688581 | 定价权·品牌 | 医疗器械 | 19.3 | 17.0 | 1.13 | 1.62 | 2.0% | 38% | 71% | 8% | 0.3 | 3.6% | +17% | +0% | -11% | -38% | -38% | 32% | 41 |
| 澳华内镜 688212 | 亏损或困境 | 医疗器械 | — | 96.0 | 0.79 | 3.40 | — | 85% | 69% | 33% | 7.7 | -2.3% | +20% | +9% | -29% | -39% | -51% | 39% | 42 |
| 济民健康 603222 | 亏损或困境 | 医疗器械 | — | — | — | 3.88 | — | — | 42% | 54% | — | -0.3% | -6% | +34% | -12% | -19% | -50% | 61% | 42 |
| 伟思医疗 688580 | 中性 | 医疗器械 | 25.1 | 24.5 | 2.72 | 2.51 | 2.4% | 75% | 72% | 25% | 0.0 | 0.4% | +13% | +82% | -6% | -19% | -36% | 54% | 42 |
| 山外山 688410 | 成长兑现 | 医疗器械 | 24.2 | 16.6 | 0.50 | 2.47 | 1.4% | 45% | 45% | 20% | 0.0 | 0.5% | +28% | +36% | -5% | -13% | -27% | 42% | 45 |
| 康泰医学 300869 | 亏损或困境 | 医疗器械 | — | — | — | 2.73 | — | 73% | 49% | 11% | — | -0.1% | -13% | +10% | -25% | -40% | -44% | 29% | 45 |
| ST凯利 300326 | 轻资产现金牛 | 医疗器械 | 20.1 | — | — | 1.56 | 1.6% | 46% | 54% | 6% | 0.3 | 4.5% | -6% | -13% | +13% | +10% | -26% | 30% | 45 |
| 基蛋生物 603387 | 中性 | 医疗器械 | 15.9 | — | — | 1.60 | 2.6% | 41% | 67% | 19% | 0.9 | 6.6% | -17% | +4% | +13% | +8% | -28% | 38% | 47 |
| 三鑫医疗 300453 | 现金流红利 | 医疗器械 | 17.0 | — | — | 3.21 | 3.3% | 59% | 35% | 49% | 0.5 | 4.1% | +7% | +22% | +8% | -8% | -19% | 31% | 48 |
| 普门科技 688389 | 定价权·品牌 | 医疗器械 | 33.8 | 22.2 | 1.01 | 2.31 | 2.5% | 36% | 63% | 22% | 1.2 | 4.0% | +2% | -11% | -12% | -21% | -34% | 26% | 48 |
| 三友医疗 688085 | 纯久期 | 医疗器械 | 92.6 | 47.9 | 0.96 | 2.35 | 0.1% | 10% | 80% | 13% | 0.3 | 1.0% | -6% | +2% | -16% | -33% | -51% | 46% | 50 |
| 春立医疗 688236 | 轻资产现金牛 | 医疗器械 | 19.6 | 16.6 | 0.75 | 1.79 | 2.5% | 50% | 72% | 13% | 0.0 | 4.4% | -4% | +82% | -37% | -37% | -54% | 44% | 54 |
| 采纳股份 301122 | 中性 | 医疗器械 | 903.8 | 63.9 | 2.56 | 2.93 | 0.1% | 58% | 39% | 33% | 2.4 | -1.2% | -8% | +30% | +74% | +90% | -32% | 60% | 55 |
| 奥美医疗 002950 | 中性 | 医疗器械 | 22.9 | — | — | 1.51 | 1.6% | 16% | 29% | 33% | 1.4 | -0.3% | -4% | +26% | -18% | -8% | -41% | 48% | 56 |
| 迈克生物 300463 | 亏损或困境 | 医疗器械 | — | 73.9 | 0.74 | 0.89 | — | 40% | 55% | 48% | 2.5 | 1.3% | -16% | -15% | -17% | -28% | -43% | 32% | 56 |
| 博拓生物 688767 | 中性 | 医疗器械 | 275.9 | 54.6 | 2.60 | 2.62 | 1.9% | 186% | 53% | 24% | 1.8 | -1.3% | -38% | +70% | +1% | -7% | -37% | 61% | 56 |
| 华强科技 688151 | 纯久期 | 医疗器械 | 119.0 | — | — | 1.36 | 0.3% | 47% | 23% | 13% | — | 0.5% | +2% | +33% | -19% | -34% | -44% | 38% | 57 |
| 亚辉龙 688575 | 中性 | 医疗器械 | 86.0 | 34.1 | 1.18 | 2.10 | 0.2% | 43% | 57% | 39% | 1.8 | 2.8% | -23% | -9% | -29% | -38% | -48% | 33% | 58 |
| 瑞迈特 301367 | 中性 | 医疗器械 | 26.4 | 16.3 | 0.65 | 1.90 | 1.0% | 23% | 46% | 1% | 0.6 | 2.3% | -6% | +37% | -24% | -32% | -44% | 47% | 58 |
| 蓝帆医疗 002382 | 重资产陷阱 | 医疗器械 | — | 12.4 | 0.83 | 0.84 | — | — | 16% | 32% | 3.2 | 3.1% | +5% | +9% | +6% | -9% | -41% | 37% | 60 |
| 楚天科技 300358 | 中性 | 医疗器械 | 14.7 | — | — | 1.08 | 0.8% | 17% | 32% | 21% | 1.6 | 12.9% | -4% | +43% | -13% | -4% | -38% | 48% | 60 |
| 正川股份 603976 | 中性 | 医疗器械 | 359.4 | — | — | 5.25 | 0.7% | 99% | 21% | 41% | 2.8 | 1.6% | -6% | +22% | +88% | +64% | -23% | 46% | 61 |
| 翔宇医疗 688626 | 中性 | 医疗器械 | 77.8 | 65.5 | 2.52 | 3.05 | 0.4% | 36% | 67% | 43% | 4.6 | -0.5% | +16% | +108% | -34% | -35% | -54% | 57% | 64 |
| 华康洁净 301235 | 中性 | 医疗器械 | 58.0 | 24.3 | 0.53 | 3.41 | 0.3% | 10% | 37% | 10% | 5.2 | -3.4% | +24% | +84% | +28% | +39% | -56% | 81% | 65 |
| 浩欧博 688656 | 中性 | 医疗器械 | 239.5 | — | — | 7.98 | 0.2% | 54% | 63% | 71% | 0.3 | 0.8% | +8% | +62% | -32% | -16% | -63% | 55% | 66 |
| 艾德生物 300685 | 定价权·品牌 | 医疗器械 | 19.8 | 16.2 | 1.01 | 3.53 | 2.6% | 47% | 84% | 8% | 0.4 | 4.9% | +12% | -9% | -14% | -30% | -36% | 37% | 67 |
| 麦克奥迪 300341 | 中性 | 医疗器械 | 35.1 | — | — | 3.35 | 0.5% | 21% | 43% | 17% | 0.1 | 0.6% | -5% | -6% | -20% | -28% | -42% | 38% | 67 |
| 理邦仪器 300206 | 中性 | 医疗器械 | 19.4 | — | — | 3.09 | 2.6% | 59% | 57% | 24% | 0.1 | 5.0% | +5% | +17% | -6% | -8% | -28% | 40% | 68 |
| 超研股份 301602 | 纯久期 | 医疗器械 | 63.7 | — | — | 5.18 | 0.9% | 34% | 69% | 8% | — | 1.4% | +6% | — | -25% | -43% | -50% | 38% | 69 |
| 赛诺医疗 688108 | 亏损或困境 | 医疗器械 | 82.3 | 81.7 | 2.40 | 6.92 | — | — | 63% | 6% | 0.8 | 2.5% | +40% | +97% | -14% | -51% | -59% | 62% | 69 |
| 九强生物 300406 | 成长兑现 | 医疗器械 | 30.7 | 16.9 | 0.77 | 2.01 | 8.9% | 44% | 75% | 10% | 2.0 | 7.8% | -4% | +5% | -4% | -14% | -26% | 29% | 69 |
| 昊海生科 688366 | 现金流红利 | 医疗器械 | 45.3 | 20.9 | 1.31 | 1.30 | 3.3% | 111% | 70% | 25% | 1.0 | 1.2% | +5% | -27% | -30% | -47% | -49% | 29% | 69 |
| 天智航 688277 | 亏损或困境 | 医疗器械 | — | — | — | 5.79 | — | — | 69% | 26% | — | -2.3% | +21% | +52% | -2% | -26% | -47% | 60% | 69 |
| 健信超导 688805 | 纯久期 | 医疗器械 | 75.1 | 88.1 | 3.83 | 5.68 | 0.7% | 50% | 26% | 10% | 0.0 | -0.6% | +17% | — | -1% | — | -40% | 63% | 69 |
| 中红医疗 300981 | 亏损或困境 | 医疗器械 | 174.7 | — | — | 1.35 | 2.1% | — | 12% | 23% | 4.7 | 0.7% | +15% | +10% | +35% | +4% | -42% | 56% | 71 |
| 五洲医疗 301234 | 中性 | 医疗器械 | 306.5 | — | — | 9.54 | 0.2% | 51% | 21% | 33% | 0.0 | 0.3% | -6% | +72% | +153% | +148% | -32% | 71% | 73 |
| 达安基因 002030 | 亏损或困境 | 医疗器械 | — | — | — | 1.08 | — | 20% | 50% | 18% | 1.9 | 2.8% | -60% | +5% | -9% | -24% | -37% | 42% | 76 |
| 爱博医疗 688050 | 中性 | 医疗器械 | 32.0 | 19.0 | 1.00 | 2.64 | 0.8% | 34% | 76% | 30% | 2.2 | 2.8% | +37% | -33% | -35% | -50% | -56% | 31% | 76 |
| 万东医疗 600055 | 亏损或困境 | 医疗器械 | — | — | — | 1.76 | — | 54% | 42% | 6% | — | -3.1% | +6% | +4% | -30% | -39% | -46% | 30% | 76 |
| 新华医疗 600587 | 中性 | 医疗器械 | 18.0 | 12.0 | 1.20 | 0.97 | 2.8% | 35% | 26% | 21% | 1.2 | 7.2% | +2% | -11% | -11% | -24% | -32% | 26% | 77 |
| 英诺特 688253 | 纯久期 | 医疗器械 | 154.8 | — | — | 3.85 | 0.8% | 31% | 77% | 5% | 0.1 | 0.3% | -2% | -16% | +92% | +75% | -24% | 54% | 78 |
| 万孚生物 300482 | 亏损或困境 | 医疗器械 | — | 20.0 | 1.11 | 1.47 | 1.3% | 35% | 58% | 20% | 5.2 | 8.7% | -28% | -10% | -14% | -27% | -38% | 44% | 78 |
| 爱迪特 301580 | 中性 | 医疗器械 | 37.8 | 28.3 | 0.59 | 3.60 | 0.6% | 27% | 49% | 8% | 0.0 | 1.7% | +20% | +8% | +69% | +49% | -45% | 72% | 79 |
| 开立医疗 300633 | 中性 | 医疗器械 | 52.3 | 27.9 | 0.82 | 2.85 | 0.9% | 30% | 67% | 27% | 1.1 | -0.4% | +9% | -10% | -23% | -40% | -51% | 35% | 86 |
| 微电生理 688351 | 纯久期 | 医疗器械 | 148.2 | 131.6 | 3.21 | 4.78 | 0.1% | 19% | 64% | 9% | 0.1 | -0.3% | +21% | +22% | -20% | -29% | -36% | 43% | 87 |
| 中源协和 600645 | 纯久期 | 医疗器械 | 74.4 | — | — | 2.33 | — | — | 69% | 10% | 0.2 | 3.2% | -2% | +31% | -26% | -34% | -49% | 44% | 87 |
| 热景生物 688068 | 亏损或困境 | 医疗器械 | — | — | — | 3.58 | — | 64% | 57% | 29% | — | -3.5% | -52% | +162% | -42% | -62% | -68% | 73% | 87 |
| 三诺生物 300298 | 成长兑现 | 医疗器械 | 66.9 | 22.7 | 0.99 | 3.01 | — | 38% | 55% | 30% | 2.0 | 4.8% | +18% | -33% | -6% | -25% | -36% | 25% | 89 |
| 威高骨科 688161 | 中性 | 医疗器械 | 34.6 | 27.8 | 1.39 | 2.14 | 1.5% | 52% | 66% | 8% | 0.1 | 3.7% | -6% | +12% | -19% | -29% | -44% | 37% | 90 |
| 圣湘生物 688289 | 纯久期 | 医疗器械 | 68.4 | 35.8 | 1.70 | 1.31 | 3.3% | 112% | 72% | 13% | 5.5 | -0.6% | -37% | -15% | -14% | -27% | -36% | 35% | 92 |
| 力诺药包 301188 | 中性 | 医疗器械 | 310.7 | 72.5 | 2.42 | 4.75 | 0.3% | 36% | 21% | 37% | 1.8 | -4.8% | +6% | +18% | +98% | +78% | -56% | 76% | 93 |
| 佰仁医疗 688198 | 中性 | 医疗器械 | 58.6 | 39.5 | 0.86 | 7.76 | 1.1% | 75% | 89% | 33% | 0.3 | 0.1% | +28% | -1% | -34% | -41% | -46% | 41% | 97 |
| 海尔生物 688139 | 中性 | 医疗器械 | 38.2 | 34.0 | 2.43 | 2.20 | 1.1% | 40% | 48% | 16% | 0.3 | 3.0% | -7% | -9% | -2% | -12% | -33% | 33% | 97 |
| 海泰新光 688677 | 中性 | 医疗器械 | 56.8 | 45.3 | 1.56 | 7.32 | 0.7% | 46% | 64% | 30% | 0.7 | 1.1% | +8% | +17% | +92% | +81% | -62% | 77% | 98 |
| 欧普康视 300595 | 定价权·品牌 | 医疗器械 | 21.4 | 19.4 | 1.76 | 1.96 | 1.7% | 35% | 75% | 7% | 0.3 | 5.7% | +7% | -22% | -24% | -42% | -45% | 29% | 99 |
| 心脉医疗 688016 | 定价权·品牌 | 医疗器械 | 18.8 | 16.9 | 1.21 | 2.52 | 2.6% | 77% | 75% | 17% | 0.0 | 2.7% | +15% | -15% | -4% | -26% | -26% | 32% | 107 |
| 东富龙 300171 | 中性 | 医疗器械 | 41.0 | — | — | 1.35 | 0.8% | 30% | 35% | 16% | 0.2 | 3.6% | -2% | +19% | -10% | -8% | -41% | 39% | 107 |
| 福瑞医科 300049 | 纯久期 | 医疗器械 | 67.2 | 45.5 | 1.34 | 5.68 | 0.4% | 26% | 74% | 14% | 0.5 | 2.0% | +16% | +124% | -40% | -33% | -58% | 60% | 112 |
| 可孚医疗 301087 | 成长兑现 | 医疗器械 | 30.1 | 25.0 | 1.04 | 2.21 | 3.4% | 98% | 44% | 22% | 1.3 | 3.6% | +4% | +34% | +19% | +34% | -28% | 42% | 122 |
| 健帆生物 300529 | 现金流红利 | 医疗器械 | 23.7 | 19.3 | 1.93 | 3.72 | 3.2% | 75% | 81% | 36% | 1.5 | 3.4% | -7% | -32% | -19% | -34% | -37% | 27% | 124 |
| 山东药玻 600529 | 中性 | 医疗器械 | 18.4 | 15.9 | 1.45 | 1.48 | 2.4% | 44% | 30% | 35% | 0.0 | 3.3% | +2% | -21% | -3% | -17% | -23% | 20% | 127 |
| 美好医疗 301363 | 中性 | 医疗器械 | 43.5 | 28.8 | 1.11 | 3.46 | 1.2% | 21% | 42% | 38% | 0.2 | 0.9% | +5% | +5% | -6% | -15% | -50% | 67% | 128 |
| 北芯生命 688712 | 亏损或困境 | 医疗器械 | 105.5 | — | — | 7.15 | — | — | 64% | 4% | 0.4 | 1.3% | +80% | — | — | — | -37% | 51% | 130 |
| 威高血净 603014 | 中性 | 医疗器械 | 26.6 | 23.9 | 2.17 | 1.81 | 1.7% | 55% | 43% | 38% | 0.0 | 4.3% | +3% | — | -20% | -20% | -35% | 37% | 131 |
| 华兰股份 301093 | 中性 | 医疗器械 | 551.5 | 111.4 | 3.28 | 6.09 | 0.1% | 52% | 42% | 27% | 1.2 | -0.3% | +2% | +182% | +59% | +134% | -48% | 78% | 133 |
| 南微医学 688029 | 中性 | 医疗器械 | 28.6 | 24.2 | 1.34 | 3.49 | 1.9% | 51% | 64% | 19% | 0.3 | 3.1% | +17% | +24% | -3% | -14% | -33% | 40% | 146 |
| 大博医疗 002901 | 中性 | 医疗器械 | 24.1 | — | — | 4.85 | 1.4% | 58% | 70% | 22% | 0.4 | 4.1% | +22% | +57% | -12% | -29% | -33% | 34% | 171 |
| 安图生物 603658 | 现金流红利 | 医疗器械 | 19.0 | 16.7 | 1.19 | 2.17 | 4.0% | 70% | 65% | 31% | 0.0 | 3.4% | -2% | -17% | -3% | -20% | -30% | 23% | 188 |
| 振德医疗 603301 | 中性 | 医疗器械 | 77.4 | — | — | 3.78 | 0.4% | 45% | 35% | 41% | 1.9 | 0.2% | -11% | +234% | +16% | +238% | -35% | 53% | 214 |
| 乐普医疗 300003 | 中性 | 医疗器械 | 28.1 | 20.2 | 1.19 | 1.32 | 2.8% | 62% | 62% | 14% | 3.5 | 2.7% | -15% | +44% | -25% | -42% | -44% | 43% | 216 |
| 华大智造 688114 | 亏损或困境 | 医疗器械 | — | — | — | 3.43 | — | — | 56% | 24% | 4.1 | 1.0% | -13% | +30% | -5% | -22% | -42% | 56% | 241 |
| 鱼跃医疗 002223 | 定价权·品牌 | 医疗器械 | 23.0 | 16.7 | 1.04 | 1.94 | 4.6% | 44% | 50% | 11% | 0.0 | 5.4% | +4% | +7% | -31% | -29% | -45% | 30% | 259 |
| 奕瑞科技 688301 | 中性 | 医疗器械 | 39.4 | 29.5 | 0.98 | 3.68 | 0.7% | 31% | 55% | 48% | 3.0 | -3.9% | +13% | +50% | +27% | +14% | -45% | 54% | 284 |
| 九安医疗 002432 | 中性 | 医疗器械 | 7.1 | — | — | 1.36 | 2.2% | 11% | 64% | 1% | — | -1.9% | -63% | -1% | +76% | +68% | -39% | 64% | 315 |
| 万泰生物 603392 | 亏损或困境 | 医疗器械 | — | — | — | 2.98 | — | 32% | 86% | 24% | — | -1.5% | -45% | -36% | -38% | -56% | -57% | 36% | 350 |
| 英科医疗 300677 | 中性 | 医疗器械 | 31.2 | 16.0 | 0.73 | 1.87 | 0.4% | 10% | 24% | 28% | 5.3 | 2.8% | +14% | +55% | +40% | +41% | -42% | 55% | 355 |
| 惠泰医疗 688617 | 中性 | 医疗器械 | 38.1 | 34.3 | 1.32 | 11.53 | 0.4% | 50% | 71% | 24% | 0.0 | 2.4% | +29% | -5% | +4% | -11% | -45% | 42% | 356 |
| 新产业 300832 | 定价权·品牌 | 医疗器械 | 23.6 | 21.8 | 1.28 | 4.51 | 2.3% | 56% | 71% | 18% | 0.0 | 4.1% | +14% | -20% | -6% | -13% | -43% | 34% | 405 |
| 联影医疗 688271 | 中性 | 医疗器械 | 50.6 | 39.1 | 1.56 | 4.06 | 0.3% | 13% | 48% | 19% | 0.7 | -0.1% | +14% | -0% | -13% | -20% | -38% | 34% | 895 |
| 迈瑞医疗 300760 | 定价权·品牌 | 医疗器械 | 26.2 | 23.9 | 1.71 | 5.08 | 2.5% | 65% | 64% | 18% | 0.0 | 4.4% | +3% | -24% | -10% | -30% | -45% | 28% | 2059 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。